(Q39737188)

English

Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients (English)

1 reference

Europe PubMed Central

14 September 2017

radiation therapy

0 references

author name string

Branislav Jeremić

1

1 reference

Europe PubMed Central

14 September 2017

Biljana Miličić

2

1 reference

Europe PubMed Central

14 September 2017

Slobodan Milisavljevic

3

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

10 January 2011

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

117

1 reference

Europe PubMed Central

14 September 2017

13

1 reference

Europe PubMed Central

14 September 2017

2995-3003

1 reference

Europe PubMed Central

14 September 2017

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Clinical biostatistics. XIV. The purposes of prognostic stratification.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Prognostic factors in lung cancer: tables and comments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Prognostic factors in non-small cell lung cancer: a decade of progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

21 January 2018

Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Illusion and reality: practical pitfalls in interpreting clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": a clinical biologist's point of view

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25910

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25910

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39737188&oldid=2089222913"